Email to HCPs from NovoSeven RT: Would you recognize acquired hemophilia?




Brand: Novoseven RT (coagulation - factor VIIa), Intravenous Infusion
Parent Company: Novo Nordisk
Drug Type: Boxed Warning
Drug Category: Hematology
Campaign: Post-Launch
Targeting: HCPs
Patient Website: https://www.novosevenrt.com/
HCP Website: https://www.novosevenrtpro.com/

Subject line: Would you recognize acquired hemophilia?

From: Novo Nordisk

Received on: Mar 26, 2018 at 12:54pm